Cancer cells can evade the body’s immune defenses by exploiting a normally helpful and ubiquitous group of molecules known as mucins. Now, Stanford researchers have engineered a biomolecule that removes mucins specifically from cancer cells—a discovery that could play a significant role in future therapies for cancer.
Click here for original story, Bioengineered tool unmasks cancer cells
Source: Phys.org